Development of an Injection Molding Process for the Production of Novel Orthotic Out-Sole Adjustable Footwear

Garnet Orthopedic Solutions是Precision Orthotics Inc.的零售商品名称，提供广泛的服务和产品，如评估步态模式，姿势和足部健康，以制造定制的矫形器，同时还纠正下半身动力链缺陷，并通过定制的足部矫形器减少个人身体和关节的整体压力。然而，骨科团队已经认识到髋后脱位引起的重大问题，这可能会对手术后的恢复产生负面影响，并对个人产生持久影响。髋关节后脱位是髋关节置换术（THA）后第二大常见并发症，影响11%的患者。如果不及时治疗，人们的病情会恶化，包括疼痛和不适的增加。目前，骨科医生没有可以长期应用的直接解决方案。Garnet已经为这个问题开发了一种解决方案，目前正在3D打印，然而，正在寻找一种注塑解决方案，以提高生产能力和降低成本。在合作中，Garnet OrthopedicSolutions和Lambton College将专注于优化3D打印设计，开发用于注塑成型的挤出材料，并将进一步设计和测试鞋和大底零件的模具。合作项目的成功将使Garnet能够以经济的方式生产鞋类，这将对人民的生活产生重大影响和改善。此外，Garnet将能够通过鞋类的制造和销售显著扩大其业务。预计在项目完成后的第一年内，每年将生产多达5000双鞋。此外，在初始收费阶段和全面生产阶段，Garnet预计还将雇佣10-20名全职员工来支持制造和生产。这款鞋的优化设计和开发将对许多加拿大人产生积极影响，帮助人们在手术后更快恢复，恢复正常，并在当地社区发挥更积极的作用。

Garnet Orthopedic Solutions is a retail trade name for Precision Orthotics Inc. that provides a wide range ofservices and products such as assessing gait patterns, posture, and foot health to fabricate custom orthotics,while also correcting lower body kinetic chain deficiencies and reduces the overall strain on an individual'sbody and joints with their custom foot orthotics. However, the orthopedist team has recognized significantissues caused by posterior hip dislocation, which can negatively affect recovery from surgery and have lastingeffects on the individual. Posterior hip dislocation is the second most common complication following hiparthroplasty (THA) that affects 11% of patients. Left untreated, conditions for people can worsen includingincreased pain and discomfort. Presently, orthopedists have no direct solution that can be applied long-term.Garnet has developed a solution for this problem that is currently being 3D printed, however, is looking for aninjection molded solution to increase production capacity and reduce costs. In collaboration, Garnet OrthopedicSolutions and Lambton College will focus on optimizing the 3D printed design, developing an extrudedmaterial ready for injection molding, and will further design and test the mold for shoe and outsole parts. Thesuccess of the collaborative project will allow Garnet to economically produce footwear that will have asignificant impact and improvement on the livelihood of the people. Additionally, Garnet will be able tosignificantly expand its business through the manufacturing and sales of footwear. It is expected that within thefirst year of initial production after the completion of the project that up to 5000 pairs of shoes will beproduced per year. Furthermore, during the initial toll stage and full production Garnet anticipates hiring anadditional 10-20 full-time employees to support manufacturing and production. The optimized design anddevelopment of the footwear will have a positive impact on many Canadians, helping people to recover quickerpost-surgery and return to a normal as well as a more active role in their local communities.